| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/19/2003 | CN1398257A Non-symmetrical ligands and catalyst systems thereof for ehtylene oligomerisation to linear alpha olefins |
| 02/19/2003 | CN1398256A Method for producing 5-aryl nicotinaldehydes |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1397551A N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide |
| 02/19/2003 | CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/18/2003 | US6521667 Calcilytic compounds |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521663 Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521643 Pyridine compounds and their pharmaceutical use |
| 02/18/2003 | US6521642 Crystal form of etoricoxib, a selective cyclooxygenase-2 inhibitor, useful in treatment of inflammation, pain and fever |
| 02/18/2003 | US6521640 Method for interviewing neuronal death using sulfasalazine |
| 02/18/2003 | US6521626 Inhibiting binding of alpha 4 integrins to their ligands; prophylaxis and treatment of immune or inflammatory disorders |
| 02/18/2003 | US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 02/18/2003 | US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/18/2003 | US6521607 (R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/18/2003 | US6521028 Quaternary ammonium salts, particularly pyridinium and quinolinium salts. By preparing these salts in a solvent selected from the group consisting of propylene glycols, propylene glycol ethers and mixtures thereof, the production |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/14/2003 | WO2002018326A1 Novel propenohydroxamic acid derivatives |
| 02/14/2003 | CA2423733A1 Novel propenohydroxamic acid derivatives |
| 02/13/2003 | WO2003011876A1 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
| 02/13/2003 | WO2003011860A2 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 02/13/2003 | WO2003011853A1 6-aryl-4-aminopicolinates and their use as herbicides |
| 02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/13/2003 | WO2003011831A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2003011829A1 Process for the production of quinazolines |
| 02/13/2003 | WO2003011828A2 3-pyridylether rerivatives and their use as analgesics |
| 02/13/2003 | WO2003011819A1 Butyric acid derivatives |
| 02/13/2003 | WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011292A1 Antivesicant compounds and methods of making and using thereof |
| 02/13/2003 | WO2003011210A2 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2002076974A3 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 02/13/2003 | WO2002067761A3 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 02/13/2003 | WO2002046249A3 Methods of copolymerizing ethylene and isobutylene and polymers made thereby |
| 02/13/2003 | WO2002037927A3 Compounds and methods for promoting smoking cessation |
| 02/13/2003 | WO2002033110A3 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
| 02/13/2003 | US20030032660 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/13/2003 | US20030032659 Stabilization of retinoid compounds |
| 02/13/2003 | US20030032656 2-Amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/13/2003 | US20030032655 Heme oxygenase-1 inducers or induction enhancers |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
| 02/13/2003 | CA2459774A1 Antivesicant compounds and methods of making and using thereof |
| 02/13/2003 | CA2455853A1 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 02/13/2003 | CA2455749A1 Butyric acid derivatives |
| 02/13/2003 | CA2451075A1 Process for the production of quinazolines |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282611A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282595A1 Novel phenyl-propargylether derivatives |
| 02/12/2003 | EP1064265A4 Synthesis of 3-amino-2-chloro-4-methylpyridine from malononitrile and acetone |
| 02/12/2003 | EP0941112B1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1396928A Process for preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/12/2003 | CN1396912A 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors |
| 02/12/2003 | CN1396903A Novel compound, their preparation and use |
| 02/12/2003 | CN1396827A Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 02/12/2003 | CN1396819A Novel coupler for use in oxidative hair dyeing |
| 02/12/2003 | CN1396807A 除草组合物 Herbicidal compositions |
| 02/11/2003 | US6518458 (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy |
| 02/11/2003 | US6518455 Process for preparing substituted aromatic and heteroaromatic aldehydes and carboxylic acids |
| 02/11/2003 | US6518433 Process for the preparation of nitroguanidine derivatives |
| 02/11/2003 | US6518432 The invention relates to a novel process for the preparation of certain pharmaceutically active pyridyl compounds. NMDA receptor antagonist activity. The compound known as (S)-1-phenyl-2-(2- pyridyl)ethanamine is of particular |
| 02/11/2003 | US6518431 Reacting 2,5-disubstituted pyridine with silalating agent |
| 02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518272 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | CA2274597C Process for producing halogenated heteroaryl compounds |
| 02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |
| 02/11/2003 | CA2222851C Keratin fibre oxidation dye composition and dye process using the composition |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | WO2003010130A1 Amino acid derivatives |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2002067851A3 Method for treating fibrotic diseases or other indications iiic |
| 02/06/2003 | WO2002066418A3 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 02/06/2003 | WO2002046194A3 Substituted imidazopyridines |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030028017 Novel synthesis for heteroarylamine compounds |
| 02/06/2003 | US20030027862 Amino-and amido-diphenyl ethers |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/06/2003 | US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes |
| 02/06/2003 | US20030027831 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases |
| 02/06/2003 | US20030027830 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer |
| 02/06/2003 | US20030027829 Potassium channel inhibitors |
| 02/06/2003 | US20030027826 Useful for treating atherosclerosis and other coronary artery disease;reacting an amine compound with an epoxide derivative in presence of transition metal salt catalyst |
| 02/06/2003 | US20030027814 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | US20030027357 ECL labels having improved non-specific binding properties, methods of using and kits containing the same |